Investment analysis, share recommendations, and market insights.
In our “HOT” stock column, Michael Gable, managing director of Fairmont Equities, explains why he sees CAR Group (CAR) as a buying opportunity.
In our “HOT” stock column, Jun Bei Liu, Portfolio Manager, Tribeca Alpha Plus Fund says that James Hardie JHX is a BUY1
Should you invest before or after the US election result? Here’s a form guide and historical look at the big race on Cup Day for the White House!
In this article, I look at how our two model portfolios have performed so far in 2024. To do so, we’ll start by examining how the overall market has fared.
In our “HOT” stock column today, Raymond Chan, Head of Asian Desk, Morgans follows up on his Resmed (RMD) call and confirms that it’s still an ADD.
Like a number of similar companies, Atlassian has huge total addressable markets to grow into, and large material upside possible. Here’s my view on this company listed on the NASDAQ but founded by two Australians.
For those who believe Trump will win and want to profit from that view through global equities, here are two Trump trades to consider via ASX-listed funds.
In our “HOT” stock column, Michael Gable, Managing Director of Fairmont Equities, explains why he expect Clarity Pharmaceuticals (CU6) to continue trending higher from here and current levels are a buying opportunity.
Both these questions are hard ones to answer but here are three stocks I’ve got out on the mat to check whether I should sell, hold or buy more.
The big broad-based listed investment companies are currently super cheap, trading at material discounts to their NTA (net tangible asset value). Why is this so? What’s the play here? What’s my view on which “big” LIC to invest in?
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.